Literature DB >> 20515820

Functional and metabolic adaptation in uraemic cardiomyopathy.

Katie Smith1, David Semple, Dunja Aksentijevic, Sunil Bhandari, Anne-Marie L Seymour.   

Abstract

Cardiovascular complications are the leading cause of death in patients with chronic kidney disease (CKD). The uraemic heart undergoes substantial remodelling, including left ventricular hypertrophy (LVH), an important determinant of heart failure. LVH results in a shift in myocardial substrate oxidation from fatty acids towards carbohydrates however, whether this metabolic adaptation occurs in the uraemic heart is unknown. The aim of this study was to investigate the progression of kidney dysfunction in parallel with cardiac remodelling in experimental uraemia. Experimental uraemia was induced surgically via a subtotal nephrectomy. At 3, 6 and 12 weeks post-surgery, renal function, LVH, in vitro cardiac function and metabolic remodelling using 13C-NMR were assessed. Uraemic animals exhibited anaemia and kidney dysfunction at 3 weeks, with further deterioration as uraemia progressed. By 12 weeks, uraemic hearts showed marked LVH, preserved cardiac function and markedly reduced fatty acid oxidation. This change in substrate preference may contribute to the deterioration of cardiac function in the uraemic heart and ultimately failure.

Entities:  

Mesh:

Year:  2010        PMID: 20515820     DOI: 10.2741/e208

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  5 in total

1.  Mitochondrial dysfunction in uremic cardiomyopathy.

Authors:  David Taylor; Sunil Bhandari; Anne-Marie L Seymour
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

2.  Myocardial bioenergetic abnormalities in experimental uremia.

Authors:  Alistair Ms Chesser; Steven M Harwood; Martin J Raftery; Muhammad M Yaqoob
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-05-24

3.  Impact of Intravenous Iron on Oxidative Stress and Mitochondrial Function in Experimental Chronic Kidney Disease.

Authors:  Faisal Nuhu; Anne-Marie Seymour; Sunil Bhandari
Journal:  Antioxidants (Basel)       Date:  2019-10-21

4.  A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status.

Authors:  S Bhandari; V Allgar; A Lamplugh; I Macdougall; P A Kalra
Journal:  BMC Nephrol       Date:  2021-03-30       Impact factor: 2.388

5.  Is rate-pressure product of any use in the isolated rat heart? Assessing cardiac 'effort' and oxygen consumption in the Langendorff-perfused heart.

Authors:  Dunja Aksentijević; Hannah R Lewis; Michael J Shattock
Journal:  Exp Physiol       Date:  2015-12-16       Impact factor: 2.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.